The World Health Organization has warned that 200 monkeypox cases found in recent weeks outside countries where the virus usually circulates could be just the beginning.
“We don’t know if we are just seeing the peak of the iceberg [or] if there are many more cases that are undetected in communities,” Sylvie Briand, WHO’s epidemic and pandemic preparedness and prevention chief, acknowledged on Friday in a briefing to countries.
Since the UK first reported a confirmed monkeypox case on 7 May, nearly 200 cases have been reported to the UN health agency in countries far from the states where the virus is endemic.
The European Center for Disease Prevention and Control has put the number of such cases at 219.
Endemic in a number of west and central African nations, monkeypox cases have suddenly been detected in more than 20 other countries around the world, including the US, Australia, the United Arab Emirates and nearly a dozen EU countries.
The Spanish health ministry said on Friday that 98 cases had been confirmed there so far, while the UK currently counts 90 verified infections.
Portugal has meanwhile registered 74 confirmed cases, health authorities said on Friday, adding that all the occurrences are in men, mainly aged below 40.
Argentina confirmed the first two cases of monkeypox in Latin America on Friday.
“We are still at the very, very beginning of this event,” Brian told member state representatives attending the World Health Assembly in Geneva. “We know that we will have more cases in the coming days,” she said, but stressed there was no need to panic.
“This is not a disease the general public should be worried about. It is not Covid or other diseases that spread fast.”
Monkeypox is related to smallpox, a deadly disease that was eradicated in 1980. But monkeypox is much less severe, with a fatality ratio of 3-6%. Most people recover within three to four weeks.
The initial symptoms include a high fever, swollen lymph nodes and chickenpox-like rash.
There is not much in the way of treatment, but some antivirals developed against smallpox exist, including one that was recently approved by the European Medicines Agency against smallpox, Briand pointed out.
Vaccines developed for smallpox have also been found to be about 85% effective in preventing monkeypox.
However, since small pox has not posed a threat in more than four decades, most people under the age of 45 have not received the vaccine, and the supplies of the jabs are very limited today.
Briand said experts were trying to determine what had spurred this “unusual situation”, saying preliminary investigations did not seem to indicate that the virus that causes monkeypox had changed or mutated.
She voiced hope that the spread could be halted. “We have a good window of opportunity to stop the transmission now,” she said. “If we put in place the right measures now, we probably can contain this easily.”
George is Digismak’s reported cum editor with 13 years of experience in Journalism